Ccg Wealth Management, LLC Cassava Sciences Inc Transaction History

Ccg Wealth Management, LLC

  • $179 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 14, 2023
BUY
$21.59 - $27.88 $188,329 - $243,197
8,723 New
8,723 $213,000
Q4 2022

Jan 19, 2023
SELL
$27.82 - $44.16 $69,550 - $110,399
-2,500 Reduced 25.34%
7,366 $0
Q3 2022

Oct 18, 2022
BUY
$16.33 - $51.06 $161,111 - $503,757
9,866 New
9,866 $413,000

Others Institutions Holding SAVA

# of Institutions
207
Shares Held
14M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $110M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Ccg Wealth Management, LLC Portfolio

Follow Ccg Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccg Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ccg Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email